A PHASE 1 STUDY OF PRALATREXATE PLUS ROMIDEPSIN REVEALS MARKED ACTIVITY IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) PERIPHERAL T-CELL LYMPHOMA (PTCL)
Amengual, J.E., Lichtenstein, R., Lue, J.K., Sawas, A., Deng, C., Lichtenstein, E., Khan, K., Kim, H., Atkins, L., Turenne, I., Rojas, C., Chiuzan, C., Cremers, S., O'Connor, O.A.Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2437_75
Date:
June, 2017
File:
PDF, 111 KB
english, 2017
File converter
More search results
More benefits 
